Skip to content

Prospective cohort study on dialysis associated spondylosis(DAS) of dialysis related amyloidosis(DRA) patients in Japan (PCDJ)

Prospective cohort study on dialysis associated spondylosis(DAS) of dialysis related amyloidosis(DRA) patients in Japan (PCDJ) - Prospective cohort study on DAS of DRA patients in Japan (PCDJ)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000004733
Enrollment
600
Registered
2010-12-16
Start date
2010-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dialysis related amyloidosis

Interventions

None listed

Sponsors

beta2-microgloblin removal therapy study group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients who correspond to all the following conditions (1)Patients who have a medical history of carpal tunnel surgery or trigger finger surgery. (2)Patients who have been undergoing hemodialysis for ten years or more. (3)Patients who are diagnosed as suspected cases or definite cases for the tentative criteria of DRA described in the report of the research and surveillance group for amyloidosis in 2009 (Scientific Research Grant of MHLW, The Project for Conquering Refractory Diseases).

Exclusion criteria

Exclusion criteria: (1)Patients who have a medical history of surgery for diseases in cervical spine of lumbar spine (2)Patients who are complicated by Rheumatoid arthritis (3)Patients who were considrered as ineligible for this trial by the attending doctor

Design outcomes

Primary

MeasureTime frame
(1)change in intervertebral height of cervical spine and lumbar spine (2)change in clinical entity [stage and form] of DSA according to the method described by Maruo et al.

Countries

Japan

Contacts

Public ContactTakahiro Kuragano

Hyogo College of Medicine Department of Internal Medicne, Division of Kidney and Dialysis

betamacl25@yahoo.co.jp0798-45-6521

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026